Inotuzumab - HY-P99264
Nur noch %1 verfügbar
Catalog #
HY-P99264
Ab
362,00 €
Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) is a humanized IgG4, κ antibody that targets human CD22. Inotuzumab can be linked to a toxic agent ozogamicin as an antibody-drug conjugate (ADC). Inotuzumab can be used for the research of acute lymphoblastic leukemia and non-Hodgkin lymphoma[1][2][3][4].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-P99264/Inotuzumab-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Dry Ice |
| Application | Cancer-programmed cell death |
| Alternative Names | Humanized Anti-CD22 Recombinant Antibody |
| CAS | 1660159-36-3 |
| Storage | Store at -80°C for 2 years |
| MWT | N/A |
| Solubility | 10 mM in DMSO |
| Clinical Information | Phase 4 |
| Target | ADC Antibody;Apoptosis;CD22 |
| Application: | Cancer-programmed cell death |
|---|